Published in Thromb Haemost on January 23, 1992
Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery. Heart (2000) 1.41
Warfarin reversal. J Clin Pathol (2004) 1.33
"Early Trigger" Intravenous Vitamin K: Optimizing Target-Driven Care in Warfarinised Patients With Hip Fracture. Geriatr Orthop Surg Rehabil (2015) 0.79
Low-Dose Vitamin K Therapy in Excessively Anticoagulated Patients: A Dose-Finding Study. J Thromb Thrombolysis (1997) 0.76
Spontaneous retromammary haemorrhage during warfarin therapy. Postgrad Med J (1998) 0.75
[Current recommendations for prevention of thromboembolic events in patients with heart valve prostheses]. Z Kardiol (2001) 0.75
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ (2007) 3.26
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol (2007) 2.97
Comprehensive clinical drug information service: first year's experience. Br Med J (1977) 2.77
Cutaneous vasculitis in patients with myelodysplasia. Br J Haematol (1990) 2.33
Serum ferritin concentration as an index of storage iron in rheumatoid arthritis. J Clin Pathol (1974) 2.30
Changing patterns of self-poisoning in a UK health district. QJM (1996) 2.13
Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol (1979) 1.95
Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) (1984) 1.83
Clinical pharmacokinetics of propranolol. Clin Pharmacokinet (1979) 1.81
Anticoagulants in venous thromboembolism. BMJ (1988) 1.77
Lidocaine plasma protein binding. Clin Pharmacol Ther (1980) 1.74
Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet (1994) 1.69
Adenosine stimulates respiration in man. Br J Clin Pharmacol (1985) 1.67
Safety of late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol (1990) 1.65
Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol (2001) 1.63
Predicting patients' warfarin requirements. Lancet (1977) 1.61
Phosphate enemas in childhood: cause for concern. BMJ (1991) 1.55
The plasma protein binding of basic drugs. Br J Clin Pharmacol (1986) 1.49
Atropine as possible contaminant of comfrey tea. Lancet (1989) 1.43
Community exposures to chemical incidents: development and evaluation of the first environmental public health surveillance system in europe. J Epidemiol Community Health (2000) 1.39
The effect of intravenous aminophylline on essential tremor. Br J Clin Pharmacol (1997) 1.38
Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol (1979) 1.36
Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Ann Intern Med (1980) 1.35
Lignocaine disposition in blood in epilepsy. Br J Clin Pharmacol (1981) 1.35
Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol (1981) 1.32
Transient bradycardia and subsequent sinus tachycardia produced by intravenous adenosine in healthy adult subjects. Br J Clin Pharmacol (1986) 1.29
High-performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluids. J Chromatogr (1983) 1.27
Free and total plasma theophylline concentrations in chronic airflow obstruction. Thorax (1984) 1.26
Accidental poisoning in children: can we admit fewer children with safety? Arch Dis Child (1991) 1.25
Iron metabolism and anaemia in pregnancy. Clin Haematol (1985) 1.24
Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br J Cancer (1997) 1.23
A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmacol (1986) 1.22
The impact of nationally distributed guidelines on the management of paracetamol poisoning in accident and emergency departments. National Poison Information Service. J Accid Emerg Med (1998) 1.22
Recent developments in the management of paracetamol (acetaminophen) poisoning. Drug Saf (1992) 1.21
A method to prevent the loss of isoniazid and acetylisoniazid in human plasma. Br J Clin Pharmacol (1983) 1.20
Determinants of the plasma protein binding of theophylline in health. Br J Clin Pharmacol (1983) 1.19
Diazepam and lidocaine plasma protein binding in renal disease. Clin Pharmacol Ther (1982) 1.19
Monitoring effects of oral anticoagulants during treatment with heparin. Br Med J (Clin Res Ed) (1984) 1.18
Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole. Br J Clin Pharmacol (1986) 1.16
Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction. Clin Pharmacol Ther (1981) 1.16
The effects of age and smoking on the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol (1985) 1.16
Adenosine-induced respiratory stimulation in man depends on site of infusion. Evidence for an action on the carotid body? Br J Clin Pharmacol (1987) 1.12
Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. QJM (2002) 1.09
Predicting the dose of warfarin for therapeutic anticoagulation. Thromb Haemost (1982) 1.09
Should we routinely measure free plasma phenytoin concentration? Br J Clin Pharmacol (1984) 1.07
Hemlock water dropwort poisoning--a review. Clin Toxicol (1978) 1.05
Importance of blood-collection tubes in plasma lidocaine determinations. Clin Chem (1979) 1.05
Erythropoiesis in the anaemia of rheumatoid arthritis. Br J Haematol (1982) 1.03
Important drug-drug interactions in the elderly. Drugs Aging (1998) 1.02
Presystemic drug elimination. Annu Rev Pharmacol Toxicol (1979) 1.01
The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. Br J Clin Pharmacol (1985) 1.01
Adverse effects of corticosteroids. Adverse Drug React Toxicol Rev (1998) 1.00
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clin Lab Haematol (1987) 1.00
Accumulation of storage iron in patients treated for iron-deficiency anaemia. Br Med J (1975) 0.99
Control of lidocaine therapy: new perspectives. Ther Drug Monit (1982) 0.96
Labetalol, a cross-over double blind controlled trial. Eur J Clin Pharmacol (1978) 0.96
Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health. Br J Clin Pharmacol (1985) 0.96
Paracetamol toxicity: is enzyme induction important? Hum Toxicol (1986) 0.95
On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction. Br J Clin Pharmacol (1982) 0.94
Guidelines to control heparin treatment. Br Med J (Clin Res Ed) (1986) 0.94
Diazepam and N-desmethyldiazepam redistribution after heparin. Clin Pharmacol Ther (1980) 0.94
Parenteral iron therapy in the anaemia of rheumatoid arthritis. Rheumatol Rehabil (1982) 0.94
The pharmacology of oral anticoagulants: implications for therapy. J Heart Valve Dis (1993) 0.94
A report of overdose with astemizole. Hum Toxicol (1986) 0.93
Association of seminal desethylamiodarone concentration and epididymitis with amiodarone treatment. Br Med J (Clin Res Ed) (1988) 0.93
Predicting warfarin requirements. Lancet (1979) 0.92
Intravenous infusion of adenosine but not inosine stimulates respiration in man. Br J Clin Pharmacol (1987) 0.91
Adenosine causes transient dilatation of coronary arteries in man. Br J Clin Pharmacol (1987) 0.90
Adenosine: an importance beyond ATP. Br Med J (Clin Res Ed) (1986) 0.89
Oral cholestyramine increases elimination of warfarin after overdose. Br Med J (Clin Res Ed) (1985) 0.89
Saliva concentrations of lidocaine and its metabolites in man. Ther Drug Monit (1982) 0.89
Evidence of active transport involvement in morphine transport via MDCKII and MDCK-PGP cell lines. Res Pharm Sci (2010) 0.89
Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics. Circulation (1982) 0.88
Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction. Thorax (1985) 0.88
Bronchospasm induced by intravenous adenosine. Hum Exp Toxicol (1994) 0.88
Plasma adenosine concentrations during adenosine-induced respiratory stimulation in man. Eur J Clin Pharmacol (1991) 0.87
Anaemia and chronic disease. Clin Haematol (1982) 0.87
Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris. Br J Clin Pharmacol (1987) 0.86
Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy. Clin Pharmacokinet (1989) 0.86
Saliva and plasma concentrations of isoniazid and acetylisoniazid in man. Br J Clin Pharmacol (1988) 0.85
Audit of control of heparin treatment. Br Med J (Clin Res Ed) (1985) 0.85
Heparin administration increases plasma warfarin binding in man. Br J Clin Pharmacol (1979) 0.85
A cluster of three cases of aplastic anaemia in children. Clin Lab Haematol (1988) 0.84
Investigation of patients with abnormal response to warfarin. Br J Clin Pharmacol (1986) 0.84
Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma. Br J Clin Pharmacol (1986) 0.84
Aplastic anaemia incidence in parts of the United Kingdom in 1985. Leuk Res (1988) 0.83
A method for the investigation of reticuloendothelial iron kinetics in man. Br J Haematol (1979) 0.83
Poisoning by hemlock water dropwort. Lancet (1977) 0.83
Amiodarone reduces plasma warfarin clearance in man. Br J Clin Pharmacol (1985) 0.82